Loading clinical trials...
Loading clinical trials...
Double-Blind, Randomized, Historical Control Study of the Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Conditions
Interventions
Eslicarbazepine acetate
Eslicarbazepine acetate
Locations
106
United States
Norwood Neurology
Birmingham, Alabama, United States
Greystone Neurology Center
Birmingham, Alabama, United States
USA Neurology
Mobile, Alabama, United States
Neurology Clinic, P.C.
Northport, Alabama, United States
Clinical Research Consortium
Phoenix, Arizona, United States
Clinical Research Consortium - Arizona
Phoenix, Arizona, United States
Start Date
April 1, 2009
Primary Completion Date
May 1, 2013
Completion Date
May 1, 2013
Last Updated
March 11, 2016
Lead Sponsor
Sumitomo Pharma America, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions